Kiseleva Olga I, Ikhalaynen Yuriy A, Kurbatov Ilya Y, Arzumanian Viktoriia A, Kryukova Polina A, Poverennaya Ekaterina V
Institute of Biomedical Chemistry, Pogodinskaya Street, 10, 119121 Moscow, Russia.
Int J Mol Sci. 2025 Apr 18;26(8):3857. doi: 10.3390/ijms26083857.
The analysis of biological fluids plays a crucial role in biomarker discovery, disease diagnostics, and precision medicine. Dried sample carriers-such as dried blood spots, dried plasma, serum, saliva, tears, and urine-have emerged as powerful tools, offering advantages in sample collection, storage, and transport, particularly in remote and resource-limited settings. Recent advances in proteomic methodologies have expanded the potential of these dried matrices, yet challenges related to protein stability, sensitivity, and standardization persist. This review critically examines the current state of proteomic investigations using dried biological fluids. Furthermore, we compare proteomics' progress in this field with other omics approaches, such as metabolomics, to contextualize its development and integration potential. While dried fluid proteomics is promising for non-invasive diagnostics and large-scale epidemiological studies, addressing technical limitations will be essential for its broader adoption in clinical and translational research.
生物流体分析在生物标志物发现、疾病诊断和精准医学中起着至关重要的作用。干燥样本载体,如干血斑、干血浆、血清、唾液、眼泪和尿液,已成为强大的工具,在样本采集、储存和运输方面具有优势,特别是在偏远和资源有限的环境中。蛋白质组学方法的最新进展扩大了这些干燥基质的潜力,但与蛋白质稳定性、灵敏度和标准化相关的挑战仍然存在。本综述批判性地审视了使用干燥生物流体进行蛋白质组学研究的现状。此外,我们将该领域蛋白质组学的进展与其他组学方法(如代谢组学)进行比较,以了解其发展和整合潜力。虽然干燥流体蛋白质组学在非侵入性诊断和大规模流行病学研究方面很有前景,但解决技术限制对于其在临床和转化研究中的更广泛应用至关重要。